文献速递肝病胰腺与胆道疾病

NAFLD、2型糖尿病与肥胖之间的因果关系及其对疾病亚表型分型的启示

Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping.
PubMed 文献 · J Hepatol · 2020-03-10

本研究利用UK Biobank和公开GWAS数据,采用两样本双向孟德尔随机化分析,探讨NAFLD、T2D和肥胖之间的因果关系,并用表达人PNPLA3-I148M的转基因小鼠验证。结果显示遗传驱动的NAFLD因果性增加T2D和中心性肥胖风险,而遗传驱动的T2D、BMI和WHRadjBMI因果性增加NAFLD风险。

要点

  • 遗传驱动的NAFLD因果性增加T2D和中心性肥胖风险,但不增加胰岛素抵抗或全身性肥胖风险。
  • 遗传驱动的T2D、BMI和WHRadjBMI均因果性增加NAFLD风险。
  • PNPLA3-I148M小鼠出现糖耐量异常和内脏脂肪增加,但胰岛素敏感性正常、体重降低。

核心结论

  • 终生遗传驱动的NAFLD因果性促进T2D(呈晚发性1型样糖尿病亚表型)和中心性肥胖。
  • 遗传驱动的T2D、肥胖和中心性肥胖均因果性增加NAFLD风险。

研究设计与样本

  • 采用UK Biobank和公开全基因组关联研究数据,进行两样本双向孟德尔随机化分析。
  • 使用表达人PNPLA3-I148M异构体的转基因小鼠(TghPNPLA3-I148M)验证因果效应并探索机制。

主要发现

  • 遗传驱动的NAFLD显著增加T2D和中心性肥胖风险,但不增加胰岛素抵抗或全身性肥胖风险。
  • 遗传驱动的T2D、体重指数和WHRadjBMI因果性增加NAFLD风险。
  • TghPNPLA3-I148M小鼠较对照出现糖耐量异常和内脏脂肪增加,但胰岛素敏感性正常、体重降低、循环总胆固醇降低。
  • TghPNPLA3-I148M小鼠胰腺胰岛素减少而胰高血糖素分泌增加,与胰腺炎症增加相关。
  • TghPNPLA3-I148M小鼠肝脏胆固醇生物合成通路基因转录受抑,皮下和棕色脂肪产热通路基因转录激活,但内脏脂肪无此变化。

临床怎么用

  • 提示NAFLD、T2D和肥胖应进一步分亚型,以利于精准诊断、预防和治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD), type 2 diabetes (T2D) and obesity are epidemiologically correlated with each other but the causal inter-relationships between them remain incompletely understood. We aimed to explore the causal relationships between the 3 diseases. METHODS: Using both UK Biobank and publicly available genome-wide association study data, we performed a 2-sample bidirectional Mendelian randomization analysis to test the causal inter-relationships between NAFLD, T2D, and obesity. Transgenic mice expressing the human PNPLA3-I148M isoforms (TghPNPLA3-I148M) were used as an example to validate causal effects and explore underlying mechanisms. RESULTS: Genetically driven NAFLD significantly increased the risk of T2D and central obesity but not insulin resistance or generalized obesity, while genetically driven T2D, body mass index and WHRadjBMI causally increased NAFLD risk. The animal study focusing on PNPLA3 corroborated these causal effects: compared to the TghPNPLA3-I148I controls, the TghPNPLA3-I148M mice developed glucose intolerance and increased visceral fat, but maintained normal insulin sensitivity, reduced body weight, and decreased circulating total cholesterol. Mechanistically, the TghPNPLA3-I148M mice demonstrated decreased pancreatic insulin but increased glucagon secretion, which was associated with increased pancreatic inflammation. In addition, transcription of hepatic cholesterol biosynthesis pathway genes was significantly suppressed, while transcription of thermogenic pathway genes was activated in subcutaneous and brown adipose tissues but not in visceral fat in TghPNPLA3-I148M mice. CONCLUSIONS: Our study suggests that lifelong, genetically driven NAFLD causally promotes T2D with a late-onset type 1-like diabetic subphenotype and central obesity; while genetically driven T2D, obesity, and central obesity all causally increase the risk of NAFLD. This causal relationship revealed new insights into how nature and nurture drive these diseases, providing novel hypotheses for disease subphenotyping. LAY SUMMARY: Non-alcoholic fatty liver disease, type 2 diabetes and obesity are epidemiologically correlated with each other, but their causal relationships were incompletely understood. Herein, we identified causal relationships between these conditions, which suggest that each of these closely related diseases should be further stratified into subtypes. This is important for accurate diagnosis, prevention and treatment of these diseases.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Liu Z, Zhang Y, Graham S, et al. Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping. J Hepatol. 2020. PMID: 32165250. doi:10.1016/j.jhep.2020.03.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。